Fractyl Health (GUTS) Operating Leases (2023 - 2026)

Fractyl Health (GUTS) has reported Operating Leases for 4 consecutive years, with $25.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases fell 5.97% year-over-year to $25.1 million; the trailing twelve-month figure through Jun 2026 stood at $25.1 million (down 5.97% YoY), and the FY2025 full-year result was $26.0 million, down 5.21% from the prior year.
• Operating Leases was $25.1 million for Q2 2026 at Fractyl Health, down from $25.5 million in the prior quarter.
• The five-year high for Operating Leases was $28.5 million in Q4 2023, with the low at $25.1 million in Q2 2026.
• Historically, Operating Leases has averaged $27.0 million across 4 years, with a median of $27.0 million in 2025.
• Annual changes were most pronounced in 2024 — Operating Leases retreated 3.95% — and 2026, when it dropped 5.97%.
• Tracing GUTS's Operating Leases over 4 years: stood at $28.5 million in 2023, then dropped by 3.95% to $27.4 million in 2024, then declined by 5.21% to $26.0 million in 2025, then dropped by 3.26% to $25.1 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $25.1 million in Q2 2026, $25.5 million in Q1 2026, and $26.0 million in Q4 2025.